Injectable Drug Delivery Devices Market Size, Share, Revenue, Trends And Drivers For 2024-2033

March 29, 2024 03:15 PM GMT | By EIN Presswire
 Injectable Drug Delivery Devices Market Size, Share, Revenue, Trends And Drivers For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, March 29, 2024 /EINPresswire.com/ -- The injectable drug delivery devices market is extensively covered in The Business Research Company’s “Injectable Drug Delivery Devices Global Market Report 2024, providing a comprehensive overview. According to TBRC's market projection, the market size for injectable drug delivery devices is anticipated to attain $61.78 billion by 2028, with a compound annual growth rate (CAGR) of 6.8%.

The increase in the injectable drug delivery devices market is attributed to the growing preference for self-injection devices. The North America region is projected to dominate the injectable drug delivery devices market share. Key players in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, B. Braun Melsungen AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, and Pfizer Inc.

Injectable Drug Delivery Devices Market Segments
• By Type: Syringes, Injectors And Pump
• By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
• By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
• Sub segments: Conventional Injectable Devices, Pre-Filled Syringes, Auto-Injectors, Pen-Injectors, Insulin Pumps, Ambulatory Infusion Devices
• By Geography: The global injectable drug delivery devices market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=2835&type=smp

Injectable drug delivery devices are used for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular.

Read More On The Injectable Drug Delivery Devices Global Market Report At:
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Market Characteristics
3. Injectable Drug Delivery Devices Market Trends And Strategies
4. Injectable Drug Delivery Devices Market – Macro Economic Scenario
5. Injectable Drug Delivery Devices Market Size And Growth
……
27. Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company?

Implantable Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Liposomal Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Drug Screening Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next